R
Repertoire Genesis
Development of new diagnostic/therapeutic methods based on immune diversity analysis
About Repertoire Genesis
Repertoire Genesis Inc. is a pioneering biotechnology company focused on developing advanced therapeutic and diagnostic methods by harnessing the power of the immune system. The company collaborates with academia and pharmaceutical firms to create innovative solutions for a wide range of medical applications, including cancer immunotherapy and autoimmune disease management. Repertoire Genesis operates in the global healthcare market, serving patients, research institutions, and pharmaceutical companies. Its business model revolves around proprietary immune diversity analysis technology, which provides accurate and comprehensive data to support medical research, prevention, diagnosis, and treatment. The company generates revenue through research and development agreements, patents, and partnerships with key stakeholders in the healthcare industry.
Source: Dealroom company dataNews
Open roles
Repertoire Genesis in the Osaka ecosystem
The Repertoire Genesis office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A2 investors entered at this stage
UTEC - The University of Tokyo Edge Capital Partners
Beyond Next Ventures
Series B and later1 investor entered at this stage
- ZKZenyaku Kogyo
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Repertoire Genesis on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Repertoire Genesis on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.


